Back to Journals » OncoTargets and Therapy » Volume 7

Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma

Total article views   HTML views PDF downloads Totals
10,455 Dovepress* 9,719+ 1,475 11,194
PubMed Central* 736 327 1,063
Totals 10,455 1,802 12,257
*Since 23 May 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar